Scarica l'app Stockscreener
4.05
2.41%
-0.10
Trevi Therapeutics Inc Azioni (TRVI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
33.28%
11.91
|
8.933 | 9.045 | 8.382 | 7.563 |
| Interest Income/Expense |
75.00%
0.001
|
0.004 | 0.003 | 0.153 | 0.231 |
| Operating Income/Loss |
33.28%
-11.91
|
-8.933 | -9.045 | -8.382 | -7.563 |
| Nonoperating Income/Loss |
11.86%
0.996
|
1.13 | 1.334 | 1.207 | 1.155 |
| Income/Loss From Continuing Operations Before Tax |
39.82%
-10.91
|
-7.803 | -7.711 | -7.175 | -6.408 |
| Income Tax Expense/Benefit |
144.44%
-0.008
|
0.018 | -0.013 | -0.03 | -0.007 |
| Income/Loss From Continuing Operations After Tax |
39.39%
-10.90
|
-7.821 | -7.698 | -7.145 | -6.401 |
|
Net Income/Loss
|
39.39%
-10.90
|
-7.821 | -7.698 | -7.145 | -6.401 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
65,161%
99.52
|
0.1525 | 99.33 | 98.70 | 98.61 |
| Diluted Average Shares |
65,161%
99.52
|
0.1525 | 99.33 | 98.70 | 98.61 |
| Basic Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.08 | -0.07 | -0.06 |
| Diluted Earnings Per Share |
37.50%
-0.11
|
-0.08 | -0.08 | -0.07 | -0.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):